China Pharma Holdings (CPHI) Invested Capital (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Invested Capital came in at $1.5 million in Q1 2026, up 55.94% YoY from $940173.0 in Q1 2025, and up 2.16% on a QoQ basis from $1.4 million in Q4 2025.
China Pharma Holdings (CPHI) Invested Capital (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 17 years of Invested Capital data on file, last reported at $1.5 million in Q1 2026.
- Quarterly Invested Capital rose 55.94% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.3 million (up 50.91% YoY) and the FY2025 annual result came in at $1.4 million, up 25.34% from the prior year.
- Invested Capital rose to $1.5 million in Q1 2026, from $1.4 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $4.3 million in Q1 2022 to a low of $940173.0 in Q1 2025.
- A 5-year average of $1.9 million and a median of $1.4 million in 2025 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2022 — Invested Capital soared 282.05% — and 2023, when it tumbled 66.73%.
- Tracing CPHI's Invested Capital over 5 years: stood at $2.4 million in 2022, then plunged by 53.55% to $1.1 million in 2023, then grew by 0.99% to $1.1 million in 2024, then increased by 25.34% to $1.4 million in 2025, then rose by 2.16% to $1.5 million in 2026.
- The last three Invested Capital figures came in at $1.5 million (Q1 2026), $1.4 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 630.00 Mn |
| 10 | China Pharma Holdings | 42.13 Mn | 41.82 Mn | 83,566.00 | 1.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.47 Mn |
| Dec 31, 2025 | 1.44 Mn |
| Sep 30, 2025 | 1.96 Mn |
| Jun 30, 2025 | 1.41 Mn |
| Mar 31, 2025 | 940,173.00 |
| Dec 31, 2024 | 1.14 Mn |
| Sep 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | 1.03 Mn |
| Dec 31, 2023 | 1.13 Mn |
| Sep 30, 2023 | 1.02 Mn |
| Jun 30, 2023 | 2.84 Mn |
| Mar 31, 2023 | 2.98 Mn |
| Dec 31, 2022 | 2.44 Mn |
| Sep 30, 2022 | 3.06 Mn |
| Jun 30, 2022 | 3.23 Mn |
| Mar 31, 2022 | 4.30 Mn |
| Dec 31, 2021 | 4.33 Mn |
| Sep 30, 2021 | 800,000.00 |
| Jun 30, 2021 | 2.17 Mn |